Smoking and Parkinson's disease: A dose-response relationship

Neurology

Volumn 52, Issue 1, 1999, Pages 115-119

  Gorell, Jay M ^a,b,c   Rybicki, Benjamin A ^a,b   Johnson, Christine Cole ^a,b   Peterson, Edward L ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SMOKING;

EID: 0032947305     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.1.115     Document Type: Article

References (27)

1. Morens DM, Grandinetti A, Reed D, White LR, Ross GW. Cigarette smoking and protection from Parkinso's disease: false association or etiologic clue? Neurology 1995;45:1041-1051.
2. Grandinetti A, Morens DM, Reed D, MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994;139: 1129-1138.
3. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994;309:901-911.
4. Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D. Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinsons disease. Am J Epidemiol 1996;144:400-404.
5. De Michele G, Filla A, Volpe G, et al. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord 1996;11:17-23.
6. Hellenbrand W, Seidler A, Robra B-P, et al. Smoking and Parkinson's disease: a case-control study in Germany. Int J Epidemiol 1997;26:328-339.
7. Liou HH, Tsai MC, Chen CJ, et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 1997;48:1583-1588.
8. Wang W, Fang X, Cheng X, Jiang D, Lin Z. A case-control study on the environmental risk factors of Parkinson's disease in Tianjin, China. Neuroepidemiology 1993;12:209-218.
9. Mayeux R, Tang M-X, Marder K, Cote LJ, Stern Y. Smoking and Parkinson's disease. Mov Disord 1994;9:207-212.
10. Godwin-Austen RB, Lee PN, Marmot MG, Stern GM. Smoking and Parkinson's disease. J Neurol Neurosurg Psychiatry 1982;45:577-581.
11. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997;48:650-658.
12. Mutch WJ, Smith WC, Scott RF. A screening and alerting questionnaire for parkinsonism. Neuroepidemiology 1991;10: 150-156.
13. Folstein M, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Wolf PA, Feldman RG, Saint-Hillaire M, et al. Precursors and natural history of Parkinson's disease: the Framingham Study. Neurology 1991;41(suppl 1):371. Abstract.
15. Rajput AH, Offord KP, Beard CM, Kurland LT. A case-control study of smoking habits, dementia and other illnesses in idiopathic Parkinson's disease. Neurology 1987;37:226-232.
16. Riggs JE. Cigarette smoking and Parkinson's disease: the illusion of a neuroprotective effect. Clin Neuropharmacol 1992;15: 88 -99.
17. Ishikawa A, Miyatake T. Effects of smoking in patients with early onset Parkinson's disease. J Neurol Sci 1993;117:28-32.
18. Tanner CM, Hubble JP, Chan P. Epidemiology and genetics of Parkinson's disease. In: Watts RL, Koller WC, eds. Movement disorders - neurologic principles and practice. New York: McGraw-Hill, 1997:137-160.
19. Paulson GW, Dadmehr N. Is there a premorbid Personality typical for Parkinson's disease? Neurology 1991;41(suppl 2): 73-76.
20. Paulson GW. Addiction to nicotine is due to high intrinsic levels of dopamine. Med Hypotheses 1992;38:206-207.
21. Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol Clin 1996;14:317-335.
22. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998; 50:1346-1350.
23. Diana JN. Tobacco smoking and nutrition. Ann NY Acad Sci 1993;686:1-11.
24. Janson AM, Moller A. Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemi-transection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 1993;57:931-941.
25. James JR, Nordberg A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav Genet 1995;25:149-159.
26. Shahi GS, Das NP, Moochhala SM. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by β-naphthoflavone-pretreatment. Neurosci Lett 1991;127:247-250.
27. Fowler JS, Volkow ND, Wang GJ, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996;379: 733-736.